Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.
Tchernychev B, Li H, Lee SK, Gao X, Ramanarasimhaiah R, Liu G, Hall KC, Bernier SG, Jones JE, Feil S, Feil R, Buys ES, Graul RM, Frenette PS, Masferrer JL.
Tchernychev B, et al. Among authors: lee sk.
Br J Pharmacol. 2021 Sep;178(17):3463-3475. doi: 10.1111/bph.15492. Epub 2021 May 30.
Br J Pharmacol. 2021.
PMID: 33864386
Free PMC article.